United States Interventional Pulmonology Market was valued at USD 0.7 Billion in 2022 and is projected to reach USD 1.3 Billion by 2030, growing at a CAGR of 8.1% from 2024 to 2030.
The U.S. interventional pulmonology market is witnessing significant growth, driven by the increasing demand for minimally invasive procedures to treat respiratory conditions. This specialty has gained immense attention in recent years due to advancements in diagnostic techniques, treatment options, and improved patient outcomes. As the population ages and the prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, and asthma rises, interventional pulmonology is poised to play a crucial role in healthcare.
Interventional pulmonology involves using advanced tools and technologies to diagnose and treat lung conditions without the need for traditional surgery. Procedures like bronchoscopy, lung biopsy, and airway stenting are becoming more common in clinical settings. These procedures offer quicker recovery times and less trauma to patients, making them highly preferred over traditional methods.
According to industry experts, the U.S. interventional pulmonology market is expected to experience a compound annual growth rate (CAGR) of 9.5% from 2023 to 2030. This growth is attributed to the increasing adoption of endoscopic techniques, enhanced imaging technologies, and the rise in prevalence of lung cancer. Furthermore, growing investments in research and development for new technologies like robotic bronchoscopy and artificial intelligence are likely to expand the market even further.
The demand for diagnostic procedures also continues to rise, with patients increasingly seeking non-invasive and highly accurate options. Interventional pulmonologists are leveraging advanced technologies such as endobronchial ultrasound (EBUS) and electromagnetic navigation bronchoscopy (ENB) to improve the precision of their treatments, ultimately enhancing patient outcomes.
Notably, a significant trend in the U.S. interventional pulmonology market is the rise of specialized pulmonology centers, which are providing patients with access to cutting-edge treatments and technologies. This has fueled market expansion by creating a more efficient delivery model for these advanced procedures.
As the interventional pulmonology field evolves, it remains critical for professionals to stay updated on the latest innovations, such as advancements in robotics and artificial intelligence, which are reshaping the industry. The market’s growth is undoubtedly intertwined with the continued development of these technologies, providing improved treatments for respiratory diseases and better outcomes for patients.
For those following technological trends, the intersection between the interventional pulmonology market and advancements in fiber optics technologies, such as those in the "100 Gigabit Fiber Optic Transceiver Market", also showcases a growing synergy. The increased demand for high-speed data transfer in medical imaging and diagnostics further supports the ongoing advancements in interventional pulmonology.
Get an In-Depth Research Analysis of the US Interventional Pulmonology Market Size And Forecast [2025-2032]
Boston Scientific
BTG
Ethicon
ENDO-FLEX
HealthTronics
Karl Storz
Medtronic
Pulmonx
Terumo Corporation
Varian Medical Systems
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Interventional Pulmonology Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Interventional Pulmonology Market
Bronchoscopy
Thoracoscopy
Needle Aspiration
Endobronchial Ultrasound (EBUS)
Catheters
Endoscopes
Bronchial Stents
Biopsy Forceps
Needles
Diagnostic Procedures
Therapeutic Procedures
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Simple Procedures
Complex Procedures
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Interventional Pulmonology Market Research Analysis
1. Introduction of the US Interventional Pulmonology Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Interventional Pulmonology Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Interventional Pulmonology Market, By Type
6. US Interventional Pulmonology Market, By Application
7. US Interventional Pulmonology Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Interventional Pulmonology Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/